Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive - Results From (Q88139733)
scientific article published on 23 May 2017
Language:
(P31) (Q13442814)
(P304) 1496-1505
(P407) (Q1860)
(P433) 10
(P478) 81
(P577) Tuesday, May 23, 2017
(P1433) (Q1955928)
(P1476) "Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive - Results From a Randomized, Placebo-Controlled, Dose-Ranging Study" (language: en)
(P2093) Koutaro Yokote
Shigeto Kanada
Osamu Matsuoka
Hisakuni Sekino
Keiji Imai
Junichi Tabira
Nobushige Matsuoka
Sandip Chaudhuri
Tamio Teramoto
other details
description scientific article published on 23 May 2017

External Links